News
Market Trends, Business Strategies, Competitive Intelligence, Clinical Trials, and Patent Trends Driving Growth from 2024 to 2029"Boston, July 10, 2025 (GLOBE NEWSWIRE) -- According to the latest ...
U.S. and Chinese researchers appear to have unlocked a novel way to stop T cells from attacking the body in MS and other ...
While data is promising, many questions remain about topics such as timing and doses in the treatment of hematologic malignancies.
Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions ...
Immune checkpoint pathways regulate T cell function and play pivotal roles in the treatment of both cancer and autoimmune ...
1d
News-Medical.Net on MSNSingle-cell sequencing maps immune changes in chronic myeloid leukemiaZhuo, C., et al. (2025). Single-cell sequencing reveals the expansion and diversity of T cell subsets in the bone marrow ...
Cartesian's mRNA-based cell therapy offers a novel, outpatient approach for autoimmune diseases. Promising results, but Phase ...
3d
News-Medical.Net on MSNInnovative bispecific antibody targets LAG-3 to treat autoimmune diseasesImmune checkpoint pathways regulate T cell function and play pivotal roles in the treatment of both cancer and autoimmune ...
1d
Medpage Today on MSNEmerging Myasthenia Gravis TreatmentsIn recent years, the FDA has approved three complement inhibitors for gMG -- eculizumab (Soliris), ravulizumab (Ultomiris), ...
Olalekan O. Oluwole discusses how CAR T-cell therapy is used to treat high-risk hematologic malignancies like lymphoma and ...
ALLO-316 shows promising results in advanced renal cell carcinoma, with a 25% response rate and rapid treatment turnaround, ...
6d
AZoLifeSciences on MSNStudy Links Cell Surface Receptor Pairing to Proper Embryonic Body ShapeDuring animal development, cells divide and arrange themselves in a coordinated way, eventually forming the embryo.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results